Rentokil Initial Plc Stock Current Valuation
| RKLIF Stock | USD 5.62 0.13 2.26% |
Valuation analysis of Rentokil Initial plc helps investors to measure Rentokil Initial's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Rentokil Initial's price fluctuation is slightly risky at this time. Calculation of the real value of Rentokil Initial plc is based on 3 months time horizon. Increasing Rentokil Initial's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Rentokil Initial plc is useful when determining the fair value of the Rentokil pink sheet, which is usually determined by what a typical buyer is willing to pay for full or partial control of Rentokil Initial. Since Rentokil Initial is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Rentokil Pink Sheet. However, Rentokil Initial's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.62 | Real 4.99 | Hype 5.62 | Naive 5.59 |
The real value of Rentokil Pink Sheet, also known as its intrinsic value, is the underlying worth of Rentokil Initial plc Company, which is reflected in its stock price. It is based on Rentokil Initial's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Rentokil Initial's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Rentokil Initial's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Rentokil Initial plc helps investors to forecast how Rentokil pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Rentokil Initial more accurately as focusing exclusively on Rentokil Initial's fundamentals will not take into account other important factors: Rentokil Initial plc Company Current Valuation Analysis
Rentokil Initial's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Rentokil Initial Current Valuation | 18.1 B |
Most of Rentokil Initial's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Rentokil Initial plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Rentokil Initial plc has a Current Valuation of 18.1 B. This is 148.51% higher than that of the Industrials sector and significantly higher than that of the Specialty Business Services industry. The current valuation for all United States stocks is 8.86% lower than that of the firm.
Rentokil Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Rentokil Initial's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Rentokil Initial could also be used in its relative valuation, which is a method of valuing Rentokil Initial by comparing valuation metrics of similar companies.Rentokil Initial is currently under evaluation in current valuation category among related companies.
Rentokil Fundamentals
| Return On Equity | 0.21 | |||
| Return On Asset | 0.0419 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.13 % | |||
| Current Valuation | 18.1 B | |||
| Shares Outstanding | 2.52 B | |||
| Shares Owned By Insiders | 0.69 % | |||
| Shares Owned By Institutions | 75.84 % | |||
| Price To Earning | 38.36 X | |||
| Price To Book | 9.36 X | |||
| Price To Sales | 5.35 X | |||
| Revenue | 2.96 B | |||
| Gross Profit | 2.37 B | |||
| EBITDA | 656.6 M | |||
| Net Income | 263.2 M | |||
| Cash And Equivalents | 2.37 B | |||
| Cash Per Share | 1.28 X | |||
| Total Debt | 1.26 B | |||
| Debt To Equity | 2.64 % | |||
| Current Ratio | 1.88 X | |||
| Book Value Per Share | 0.77 X | |||
| Cash Flow From Operations | 563.2 M | |||
| Earnings Per Share | 0.17 X | |||
| Price To Earnings To Growth | 1.21 X | |||
| Number Of Employees | 46 K | |||
| Beta | 0.43 | |||
| Market Capitalization | 15.32 B | |||
| Total Asset | 4.32 B | |||
| Retained Earnings | 2.07 B | |||
| Working Capital | (196 M) | |||
| Current Asset | 593 M | |||
| Current Liabilities | 789 M | |||
| Z Score | 7.2 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 4.32 B | |||
| Last Dividend Paid | 0.067 |
About Rentokil Initial Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Rentokil Initial plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rentokil Initial using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rentokil Initial plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Rentokil Initial plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Rentokil Initial's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Rentokil Initial Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Rentokil Initial Plc Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rentokil Initial plc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Rentokil Pink Sheet analysis
When running Rentokil Initial's price analysis, check to measure Rentokil Initial's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rentokil Initial is operating at the current time. Most of Rentokil Initial's value examination focuses on studying past and present price action to predict the probability of Rentokil Initial's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rentokil Initial's price. Additionally, you may evaluate how the addition of Rentokil Initial to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |